Citations

Showing 10 of 108104 citations.

Abstract 154: Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke
Leeuw, Frank‐Erik de , Cadenas, Israel Fernández, Słowik, Agnieszka, Conde, Jordi Jiménez, Schmidt, Reinhold, Sharma, Pankaj , Rothwell, Peter M. , Sudlow, Catherine, Debette, Stéphanie , Markus, Hugh S. , Saleheen, Danish , Danesh, John , Zand, Ramin , Worrall, Bradford B. , Woo, Daniel , Lee, Jin-moo, Irvin, Marguerite R. , Rosand, Jonathan, Kamatani, Yoichiro, Xu, Huichun , Kittner, Steven J. , Debette, Stephanie , Zand, Ramin , Tomppo, Liisa , Rannikmäe, Kristiina , Stanne, Tara M. , Putaala, Jukka , Strbian, Daniel , Jern, Christina , Boncoraglio, Giorgio B. , Lindgren, Arne G. , Lemmens, Robin , Melander, Olle , Levi, Christopher , Sudlow, Catherine, Metso, Tiina M. , Paré, Guillaume , Meschia, James F. , Rundek, Tatjana , Lee, Jin‐Moo , McDonough, Caitrin W. , Rexrode, Kathryn M. , Wassertheil-Smoller, Sylvia W , Rosand, Jonathan M. , Gieger, Christian , Müller‐Nurasyid, Martina , Salomaa, Veikko , Kamatani, Yoichiro, Walters, Robin G. , Chen, Zhengming , Dichgans, Martin , Malik, Rainer , Gaynor, Brady J. , Cole, John W. , Mitchell, Braxton D.

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.154 Get It

Introduction: Genetic studies of early-onset disease have been an effective strategy to identify novel pathways and drug targets generalizable also to later-onset disease. Few studies have investigated the sex-specific genetic associations with early-onset ischemic stroke even though several features of ischemic stroke differ between males and females. We hypothesized that stratifying the GWAS by sex would reveal novel stroke loci. Methods: We performed a transethnic ischemic stroke GWAS of 3,056 female cases and 4,462 male cases < 60 years-old and 16,192 and 16,048 sex-matched controls, respectively, from the Early Onset Stroke Genetics Consortium. Results: We identified a significant association in women with a locus in close proximity to TMX1 , a transmembrane platelet protein that inhibits platelet function. Additionally, we identified 2 other suggestive (P < 5 x 10 -6 ) loci in females (see Table), i.e., at APOH , which encodes beta2-glycoprotein I, an established GWAS locus for lipoprotein(a), and LRFN2 which has been previously reported to associate with obesity-related measures and type II diabetes. We observed suggestive evidence for association in males with MMP3/MMP12 , a known stroke susceptibility locus. Conclusions: Despite a very modest sample size, sex-specific analyses identified suggestive associations at biologically important novel loci in females and a known stroke locus in males. Further studies of sex-specific associations in both early- and later-onset ischemic stroke are needed.
Abstract 125: 3d Time-of-flight Mr Angiography At 3.0 Tesla Underestimates Disease Stage Compared To Digital Subtraction Angiography In The Evaluation Of Moyamoya Disease
Rizvi, Ahmed, Rinaldo, Lorenzo , Klaas, James P. , Meyer, Fredric B. , Brinjikji, Waleed , Larson, Anthony S. , Lanzino, Giuseppe , Lehman, Vance T. , Savastano, Luis

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.125 Get It

Introduction: Digital subtraction angiography (DSA) is currently the gold standard for evaluation of moyamoya disease (MMD) and is the basis for several grading systems. Non-invasive modalities such as MRA are also used in assessment of MMD. Accurate implementation of these staging systems for use with MRA would imply a less-invasive method of MMD monitoring. Methods: This was a single-center retrospective study that compared MRA to reference DSA studies in determining MMD severity using Berlin and modified Suzuki (mSG) grading systems A single reviewer assigned modified Suzuki and Berlin grades to all included hemispheres on both MRA and DSA. The mean difference between MRA and DSA grades for each DSA reference grade was determined utilizing both grading systems. The distribution of scores was also compared between MRA and DSA using both grading systems. Results: A total of 166 cerebral hemispheres in 90 patients were included: The mean age at MMD diagnosis was 34.8 years (standard deviation [SD] = 14.2), and fifty-three patients (63.9%) were male. Mean MRA grades were significantly lower than DSA reference grades 3 and 4 utilizing the mSG system (p = <0.0001 in both cases); A similar pattern was observed for Berlin grades 2 and 3 (p = <0.0001, Table 1 ). The distribution of modified Suzuki grades on MRA was skewed toward relatively lower grades as compared to DSA (p = <0.0001): This pattern was also true for Berlin grades as well (p = <0.0001, Table 2 ). Conclusions: DSA is essential in the evaluation of MMD, as MRA is shown to underestimate disease stage, with a greater degree of underestimation in more severe disease. We suggest DSA be performed in order to aid in appropriate treatment planning.
Abstract 12: CT Perfusion For Lesion-Symptom Mapping In Emergent Large Vessel Occlusion
Brinjikji, Waleed , Abbasi, Mehdi , Kallmes, David F. , Neuhaus, Ain , Rabinstein, Alejandro A. , Harston, George , Joly, Olivier

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.12 Get It

Introduction: Selection criteria for endovascular thrombectomy (EVT) for emergent large-vessel occlusion (ELVO) stroke increasingly rely on CT perfusion (CTP) findings at presentation. While perfusion imaging is used to estimate the likelihood of deriving long-term functional benefit from EVT, there is comparatively little data on how perfusion deficits relate to domains of neurological function. Here, we investigated region-specific hypoperfusion as a driver of neurological dysfunction through correspondence between NIHSS items and CTP. Methods: We included 169 patients with ELVO presenting to Mayo Clinic Rochester or Jacksonville, who had baseline CTP and itemised NIHSS data. Perfusion was quantified as mean transit time using e-CTP (Brainomix Ltd., Oxford, UK) and thresholded to ≥5 s for lesion masking. Voxel-wise lesion-symptom mapping (VLSM) was performed using sparse canonical correlations analysis (Lesymap package, R). Results: Total NIHSS was most strongly predicted by left MCA territory hypoperfusion, corresponding to language-eloquent cortical areas and dominant hemisphere motor tracts (figure 1). Contralateral limb motor deficits (NIHSS 5 and 6) were mainly associated with subcortical and white matter hypoperfusion; there was an additional strong signal for left frontal cortex in language function (NIHSS 9). The remaining NIHSS items were less well localised. Conclusions: Expanding on previous pilot data, our results provide further evidence for the feasibility of hypoperfusion-to-symptom mapping in ELVO. This could allow for more nuanced clinical-imaging mismatch determination, and selection of patients based on specific neurological deficits that may be reversible.
Medication non‐adherence as a cause of apixaban failure in venous thromboembolism: The importance of pharmacist medication reconciliation
Jethwa, Trisha E, Moran, Kaitlin M , Maniaci, Michael J. , Maniaci, Michael J , Jethwa, Trisha

Mayo Clinic

Clinical Case Reports | February 3, 2022 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/ccr3.5338 | PMID 35140953 Get It

AbstractVenous thromboembolism is often treated with direct oral anticoagulants. In order for direct oral anticoagulants to be effective, patients must adhere to a specific dosing strategy. We report a case of apixaban failure, the clinical workup that ensued, and the eventual discovery of unsuccessful medication adherence as the cause.
Gastrointestinal motility disorders in patients with multiple sclerosis: A single‐center study
Khanna, Lehar, Zeydan, Burcu , Kantarci, Orhun H. , Camilleri, Michael , Zeydan, Burcu

Mayo Clinic

Neurogastroenterology & Motility | February 3, 2022 | Volume: 34 | Issue: 8 | Pages: No page available

10.1111/nmo.14326 | PMID 35112759 Get It

Abstract Background Most prevalent gastrointestinal symptoms in multiple sclerosis (MS) relate to lower bowel dysfunction, often in association with bladder manifestations. Objective To assess clinical and objective gastrointestinal motor dysfunctions in patients with MS. Methods This was a single‐center, retrospective study of 166 patients evaluated between 1996 and 2020. We reviewed characterization of the MS, gastrointestinal and neurological symptoms, measurements of gastrointestinal and colonic transit, and anorectal manometry. Key Results At the time of the gastrointestinal evaluations of the 166 patients with MS (138 women; 83%), 111 were in the relapsing‐remitting phase and 52 were in the progressive phase. In 3 patients, disease phase was not assigned due to insufficient data. Constipation was identified in 82% (136/166) of patients. Most [103/116 (88%)] patients with bladder symptoms also had constipation or fecal incontinence. Delayed gastric emptying at 4 h and colonic transit at 24 h was identified in 16% and 7% of the cohort, respectively; 22% had accelerated gastric emptying. On anorectal manometry, resting anal sphincter pressure >90 mm Hg and rectoanal pressure differential below −50mm Hg suggested evacuation disorder in patients with constipation. Conclusions and Inferences In addition to slow colonic transit and anorectal dysfunction leading to constipation in MS, 22% of patients had accelerated gastric emptying.
Is the use of a combined FABA/ICS single inhaler for mild asthma effective and safe?
Morgenstern‐Kaplan, Dan , Gonzalez‐Estrada, Alexei , Gonzalez-Estrada, Alexei

Mayo Clinic

Clinical & Experimental Allergy | February 3, 2022 | Volume: 52 | Issue: 3 | Pages: 372-374

10.1111/cea.14101 | PMID 35112743 Get It

Myelomatous ascites and pleural effusion in relapsed multiple myeloma
Baksh, Mizba , Jiang, Liuyan , Alegria, Victoria R., Sher, Taimur , Chanan‐Khan, Asher , Ailawadhi, Sikander , Parrondo, Ricardo , Moustafa, Muhamad Alhaj , Alegria, Victoria, Chanan-Khan, Asher, Ailawadhi, Sikander , Parrondo, Ricardo D , Moustafa, Muhamad Alhaj , Baksh, Mizba , Li, Ke , Roy, Vivek

Mayo Clinic

Clinical Case Reports | February 3, 2022 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/ccr3.5329 | PMID 35140947 Get It

AbstractExtramedullary multiple myeloma is seen in advanced and aggressive disease and occurs due to plasma cell infiltration of sites other than the bone marrow. Myelomatous ascites or pleural effusion is seen in less than 1% of cases and can be differentiated from infectious etiologies based on fluid cytology.
Margin-aware intraclass novelty identification for medical images
Guo, Xiaoyuan , Gichoya, Judy W. , Purkayastha, Saptarshi , Banerjee, Imon , Banerjee, Imon , Purkayastha, Saptarshi , Gichoya, Judy W.

Mayo Clinic

Journal of Medical Imaging | February 3, 2022 | Volume: 9 | Issue: 01 | Pages: No page available

10.1117/1.jmi.9.1.014004 | PMID 35127968 Get It

Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study
Sperling, Michael R. , Wheless, James W. , Dlugos, Dennis , Cascino, Gregory D. , Liow, Kore , Rabinowicz, Adrián L. , Carrazana, Enrique , Group, DIAZ 001.05 Study, Hogan, R Edward , Rabinowicz, Adrian L , Carrazana, Enrique , Sperling, Michael R , Wheless, James W , Group, DIAZ 001.05 Study

Mayo Clinic

Epilepsia | February 2, 2022 | Volume: 63 | Issue: 4 | Pages: 836-843

10.1111/epi.17177 | PMID 35112342 Get It

Abstract Objective An exploratory analysis from a long‐term, phase 3, open‐label, repeat‐dose safety study of diazepam nasal spray for acute treatment of seizure clusters assessed the use of a second dose up to 24 hours after the initial dose and effectiveness in potentially reducing the number of seizures. Methods Seizures and doses were recorded in diaries. Results Of 175 patients enrolled, 163 received ≥1 dose of diazepam nasal spray and were included in the safety population; those patients received a total of 4390 doses for a total of 3853 seizure clusters. Less than half of these patients used a second dose a least once during the study (79 patients [48.5%]), with a total of 485 second doses for seizure clusters (12.6% of all seizure clusters). Among these 79 patients, 33 (41.8%) used only one second dose during the study (range: 1–82). The proportion of seizure clusters treated with a second dose over time was consistently low across 24 h: 0–4 h, 152 (3.9%); 4–6 h, 72 (1.9%); 6–8 h, 39 (1.0%); 8–12 h, 55 (1.4%); 12–16 h, 42 (1.1%); 16–20 h, 42 (1.1%); 20–24 h, 83 (2.2%). Rates of treatment‐emergent adverse events (TEAEs) and treatment‐related TEAEs occurring within 1 day of a second dose were low (15.2% and 5.1%, respectively). Significance Patients with epilepsy may experience seizure clusters lasting up to 24 hours, and little is known about the effectiveness of rescue therapies for that duration. The current labeling of the US Food and Drug Administration (FDA)–approved outpatient treatments for seizure clusters (rectal diazepam, intranasal midazolam, and diazepam nasal spray) allows for a second dose, if needed, for control. These findings support the safety profile of second doses, and the low use supports the effectiveness of diazepam nasal spray across 24 hours.